EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TAK-994 mechanistic investigation into drug-induced liver injury

Tadahiro Shinozawa, Kazumasa Miyamoto, Kevin S Baker, Samantha C Faber, Ramon Flores, Jack Uetrecht, Christian von Hehn, Tomoya Yukawa, Kimio Tohyama iD, Harisha Kadali, Marcin von Grotthuss, Yusuke Sudo und 6 weitere

Toxicological Sciences · 01.04.2025 · 204 (2) · 143-153

DOI: 10.1093/toxsci/kfaf003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 09.01.2025. Verfasst von Tadahiro Shinozawa und 17 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Hepatocytes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Development Center Americas, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The frequency of drug-induced liver injury (DILI) in clinical trials remains a challenge for drug developers despite advances in human hepatotoxicity models and improvements in reducing liver-related attrition in preclinical species. TAK-994, an oral orexin receptor 2 agonist, was withdrawn from phase II clinical trials due to the appearance of severe DILI. Here, we investigate the likely mechanism of TAK-994 DILI in hepatic cell culture systems examined cytotoxicity, mitochondrial toxicity, impact on drug transporter proteins, and covalent binding. Hepatic liabilities were absent in rat and nonhuman primate safety studies, however, murine studies initiated during clinical trials revealed hepatic single-cell necrosis following cytochrome P450 induction at clinically relevant doses. Hepatic cell culture experiments uncovered wide margins to known mechanisms of intrinsic DILI, including cytotoxicity (>100× Cmax/IC50), mitochondrial toxicity (>100× Cmax/IC50), and bile salt efflux pump inhibition (>20× Css, avg/IC50). A potential covalent binding liability was uncovered with TAK-994 following hepatic metabolism consistent with idiosyncratic DILI and the delayed-onset clinical toxicity. Although idiosyncratic DILI is challenging to detect preclinically, reductions in total daily dose and covalent binding can reduce the covalent body binding burden and, subsequently, the clinical incidence of idiosyncratic DILI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryHepatocytesAnimalsHumansRatsMaleMiceLiverRats, Sprague-Dawley

Stichwörter der Autor:innen

bile salt efflux pumpcovalent bindingdrug discoverydrug-induced liver injuryhepatotoxicity

Autor:innen und Institutionen

  • Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan.
  • Takeda Development Center Americas, Inc, Cambridge, MA 02139, United States.
  • Takeda Development Center Americas, Inc, San Diego, CA 92121, United States.
  • Clarivate, 398 08025 Barcelona, Spain.
  • Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3M2, Canada.

ORCID-Profile: Kimio Tohyama

Förderung

  • Takeda Development Center Americas, Inc.

Zitieren

APA

Shinozawa, T., Miyamoto, K., Baker, K. S., Faber, S. C., Flores, R., Uetrecht, J., von Hehn, C., Yukawa, T., Tohyama, K., Kadali, H., von Grotthuss, M., Sudo, Y., Smith, E. N., Diogo, D., Zhu, A. Z. X., Dragan, Y., Cebers, G., & Wagoner, M. P. (2025). TAK-994 mechanistic investigation into drug-induced liver injury. Toxicological Sciences, 204(2), 143-153. https://doi.org/10.1093/toxsci/kfaf003

Vancouver

Shinozawa T, Miyamoto K, Baker KS, Faber SC, Flores R, Uetrecht J, et al. TAK-994 mechanistic investigation into drug-induced liver injury. Toxicological Sciences. 2025;204(2):143-153. doi:10.1093/toxsci/kfaf003

BibTeX
@article{Shinozawa2025,
  author = {Shinozawa, Tadahiro and Miyamoto, Kazumasa and Baker, Kevin S and Faber, Samantha C and Flores, Ramon and Uetrecht, Jack and von Hehn, Christian and Yukawa, Tomoya and Tohyama, Kimio and Kadali, Harisha and von Grotthuss, Marcin and Sudo, Yusuke and Smith, Erin N and Diogo, Dorothée and Zhu, Andy Z X and Dragan, Yvonne and Cebers, Gvido and Wagoner, Matthew P},
  title = {TAK-994 mechanistic investigation into drug-induced liver injury},
  journal = {Toxicological Sciences},
  year = {2025},
  volume = {204},
  number = {2},
  pages = {143--153},
  doi = {10.1093/toxsci/kfaf003}
}
Kostenlos starten →